Search research articles
Contact Us
Filters
Showing results (211-220 of 283) with videos related to
Page
of 29
Sort By:
Journal of Medicinal Chemistry
|
March 11, 2025
Structure-Activity Relationships and Evaluation of 2-(Heteroaryl-cycloalkyl)-1<i>H</i>-indoles as Tauopathy Positron Emission Tomography Radiotracers
Jeffrey S Stehouwer, Guofeng Huang, Dinahlee Saturnino Guarino, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
March 14, 2018
Open letter to journal editors on: international consensus radiochemistry nomenclature guidelines
Heinz H Coenen, Antony D Gee, Michael Adam, et al.
Nuclear Medicine Communications
|
February 14, 2018
Open letter to journal editors on: International Consensus Radiochemistry Nomenclature Guidelines
Heinz H Coenen, Antony D Gee, Michael Adam, et al.
Nuclear Medicine and Biology
|
May 26, 2019
Status of the 'consensus nomenclature rules in radiopharmaceutical sciences' initiative
Heinz H Coenen, Antony D Gee, Michael Adam, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 8, 2019
Design, synthesis, and evaluation of N-(4-(4-phenyl piperazin-1-yl)butyl)-4-(thiophen-3-yl)benzamides as selective dopamine D<sub>3</sub> receptor ligands
Peng-Jen Chen, Michelle Taylor, Suzy A Griffin, et al.
Molecular Cancer
|
July 17, 2007
Selective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: applications in diagnostic imaging and therapy
Hiroyuki Kashiwagi, Jonathan E McDunn, Peter O Simon, et al.
Nuklearmedizin. Nuclear Medicine
|
March 15, 2018
International Consensus Radiochemistry Nomenclature Guidelines
Heinz H Coenen, Antony D Gee, Michael Adam, et al.
Nuclear Medicine and Biology
|
October 28, 2017
Consensus nomenclature rules for radiopharmaceutical chemistry - Setting the record straight
Heinz H Coenen, Antony D Gee, Michael Adam, et al.
Cancer Research
|
June 5, 2016
A Radiotracer Strategy to Quantify PARP-1 Expression In Vivo Provides a Biomarker That Can Enable Patient Selection for PARP Inhibitor Therapy
Mehran Makvandi, Kuiying Xu, Brian P Lieberman, et al.
EJNMMI Radiopharmacy and Chemistry
|
October 30, 2019
Open letter to journal editors on: International Consensus Radiochemistry Nomenclature Guidelines
Heinz H Coenen, Antony D Gee, Michael Adam, et al.
Page
of 29
Search research articles
Search
Showing results (211-220 of 283) with videos related to
Sort By:
Page
of 29
Journal of Medicinal Chemistry
|
March 11, 2025
Structure-Activity Relationships and Evaluation of 2-(Heteroaryl-cycloalkyl)-1<i>H</i>-indoles as Tauopathy Positron Emission Tomography Radiotracers
Jeffrey S Stehouwer, Guofeng Huang, Dinahlee Saturnino Guarino, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
March 14, 2018
Open letter to journal editors on: international consensus radiochemistry nomenclature guidelines
Heinz H Coenen, Antony D Gee, Michael Adam, et al.
Nuclear Medicine Communications
|
February 14, 2018
Open letter to journal editors on: International Consensus Radiochemistry Nomenclature Guidelines
Heinz H Coenen, Antony D Gee, Michael Adam, et al.
Nuclear Medicine and Biology
|
May 26, 2019
Status of the 'consensus nomenclature rules in radiopharmaceutical sciences' initiative
Heinz H Coenen, Antony D Gee, Michael Adam, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 8, 2019
Design, synthesis, and evaluation of N-(4-(4-phenyl piperazin-1-yl)butyl)-4-(thiophen-3-yl)benzamides as selective dopamine D<sub>3</sub> receptor ligands
Peng-Jen Chen, Michelle Taylor, Suzy A Griffin, et al.
Molecular Cancer
|
July 17, 2007
Selective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: applications in diagnostic imaging and therapy
Hiroyuki Kashiwagi, Jonathan E McDunn, Peter O Simon, et al.
Nuklearmedizin. Nuclear Medicine
|
March 15, 2018
International Consensus Radiochemistry Nomenclature Guidelines
Heinz H Coenen, Antony D Gee, Michael Adam, et al.
Nuclear Medicine and Biology
|
October 28, 2017
Consensus nomenclature rules for radiopharmaceutical chemistry - Setting the record straight
Heinz H Coenen, Antony D Gee, Michael Adam, et al.
Cancer Research
|
June 5, 2016
A Radiotracer Strategy to Quantify PARP-1 Expression In Vivo Provides a Biomarker That Can Enable Patient Selection for PARP Inhibitor Therapy
Mehran Makvandi, Kuiying Xu, Brian P Lieberman, et al.
EJNMMI Radiopharmacy and Chemistry
|
October 30, 2019
Open letter to journal editors on: International Consensus Radiochemistry Nomenclature Guidelines
Heinz H Coenen, Antony D Gee, Michael Adam, et al.
Page
of 29